Introducing New Jersey's Premier NCI-Designated Comprehensive Cancer Care Center: Andrew Evens, DO, MBA, MSc
Cost and Coverage Issues Drive GLP-1 Discontinuation: Hamlet Gasoyan, PhD
COVID-19’s Hidden Toll: Noah Greenspan, DPT, on Inflammation, Flares, and Recovery
Global Hematology Experts Reflect on Key Takeaways From the EHA 2025 Congress
The Growing Role of AI and Other Technology in Cancer Care: Coral Omene, MD, PhD
Unaddressed Adverse Effects Undermine Patient Confidence in Lymphoma, CLL Care Plans: Lorna Warwick
Beat AML Master Trial Expands Precision Medicine Options for Patients With AML: Ashley Yocum, PhD
Phase 3 POLARGO Trial Shows Survival Benefit of Polatuzumab-Based Regimen in R/R DLBCL: Matthew Matasar, MD
Phase 3 IRAKLIA Trial Compares On-Body vs IV Isatuximab in RRMM: Xavier Leleu, MD, PhD
Lower Socioeconomic Status Tied to Worse Quality of Life in R/R Multiple Myeloma: Francesco Sparano, MSc
Early Data Show Divesiran Reduces Phlebotomy Needs in Polycythemia Vera: Marina Kremyanskaya, MD, PhD
CARTITUDE-1 Trial Shows Unprecedented 5-Year Remission in Relapsed/Refractory Multiple Myeloma: Sundar Jagannath, MBBS
Addressing Myasthenia Gravis Diagnostic Delays and Access Barriers: Marla Black Morgan, MD
AI-Based Tool for Classifying Acute Leukemia Subtypes Shows Promise in Global Study: Merlin Engelke, MS
Documentation, Collaboration Are Key to Managing Toxicities: David Awad, PharmD, BCOP
Fighting Burnout in Hematology Through Awareness, Balance: Adela Perolla, MD, PhD
Burnout in Hematology Reaches Critical Levels Amid Emotional Strain, Long Hours: Adela Perolla, MD, PhD
ADVANCE Trial Supports DKRd as New Standard of Care for Newly Diagnosed Multiple Myeloma: Ola Landgren, MD, PhD
ADVANCE Trial Aims to Modernize Frontline Multiple Myeloma Care: Ola Landgren, MD, PhD
Stem Cell Transplant Remains Cost-Effective Option for MM: Mansi Shah, MD
Rusfertide Offers Sustainable PV Management Strategy: Andrew Kuykendall, MD
Data Collection Helps the Delivery of Equitable Value-Based Cancer Care: Coral Omene, MD, PhD
Potential Impact of Loss of Coverage for Health Care Screenings: Constance Blunt, MD
Exploring Amivantamab's Potential in Colorectal Cancer: Dirk Arnold, MD, PhD
ROSELLA Trial Highlights Safe, Biomarker-Free Option for Platinum-Resistant Ovarian Cancer: Brian Slomovitz, MD
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
Retifanlimab Approval Sets New Standard of Care in Advanced Anal Cancer: Sheela Rao, MBBS, MD, FRCP
Future of Thoracic Care Is Identifying Lung Cancer Early: Samir Shah, MD, MMM, FACR
Not All Coronary Blockages Need Fixing: Merrill Stewart, MD
Improving Lupus Care Requires Addressing Social Determinants, Expanding Access: Margrit Wiesendanger, MD, PhD